August 22nd 2025
Vaginal estrogen tablets were not associated with increased risk of recurrent ischemic stroke in postmenopausal women with prior stroke.
Cognitive behavioral therapy could help mitigate sexual concerns during menopause
September 11th 2024A new study presented at the 2024 Annual Meeting of the Menopause Society found cognitive behavioral therapy can effectively address sexual concerns during menopause, improving overall well-being.
Read More
Hot flashes disrupting REM sleep linked to heart disease risk
September 10th 2024In a recent study presented at the 2024 Annual Meeting of The Menopause Society, 59% of nocturnal hot flashes occurred during the second half of the night, a time linked to increased cardiovascular disease risk.
Read More
Physical intimate partner violence linked to decreases in cognitive performance
September 10th 2024A study presented at the 2024 Annual Meeting of The Menopause Society, found that women who reported physical intimate partner violence also demonstrated decreased working memory performance over time.
Read More
Severe menopause symptoms linked to increased risk of cognitive decline in postmenopausal women
August 22nd 2024A significant connection has been identified between severe menopause symptoms and cognitive impairment in postmenopausal women, according to findings from a study published in Menopause, the journal of The Menopause Society.
Read More
Higher multimorbidity risk reported from reduced reproductive lifespan
August 12th 2024A recent study found that women with a shorter reproductive lifespan had increased odds of multimorbidity compared to those with a longer reproductive lifespan, indicating a need to assess reproductive factors to determine high-risk patients.
Read More
Study finds estrogen therapy underuse after oophorectomy raises health risks
June 19th 2024A recent highlights elevated morbidity and mortality risks in premenopausal women underusing estrogen therapy after oophorectomy, underscoring the critical need for hormone therapy to mitigate adverse health outcomes.
Read More
PCOS status linked to menopause age onset
March 28th 2024A recent regression model analysis unveils a 5% prolonged period to menopause in women with polycystic ovary syndrome, prompting further investigation into the condition's impact on reproductive health and the need for diverse longitudinal studies.
Read More
Exogenous hormones and patients at increased risk for breast cancer
October 17th 2023This lecture, presented by Holly J. Pederson, MD, at The Menopause Society 2023 Annual Meeting, looked at combined oral contraceptives in BRCA carriers and other high-risk patients, and hormone therapy in postmenopausal gene carriers as well as other high-risk women.
Read More
Hot flashes linked to Alzheimer’s disease risk
September 28th 2023In a recent study highlighted at the Menopause Society 2023 Annual Meeting, a correlation was found between the number of hot flashes experienced and the risk of Alzheimer’s disease among perimenopausal and postmenopausal women.
Read More
Alcohol and menopause: A balancing act
July 10th 2023Menopausal women who drink alcohol should limit consumption to moderate drinking, according to experts. However, binge drinking in this population has been on the rise, for which clinicians can help by referring these patients to appropriate treatment.
Read More
Study investigates vaginal estrogen for urinary symptoms of menopause
June 19th 2023Monica Christmas, MD, associate professor at the University of Chicago, discusses the findings of a study on how vaginal estrogen may be used to treat urinary symptoms in postmenopausal women, along with how she hopes these findings will impact treatment in women with urinary symptoms.
Watch
'It's about time,' fezolinetant approval and latest research showcased at annual meeting
May 19th 2023Genevieve Neal-Perry, MD, PhD, talks about the recent approval of fezolinetant (Veozah; Astellas Pharma) and her latest phase 3 research presented at the 2023 ACOG Annual Clinical and Scientific Meeting.
Watch